PROCEPT BioRobotics Corp (PRCT): who owns it and who trades it
As of Nov 16, 2026, PRCT insiders reported 14 open-market sales worth $709K and 8 purchases worth $11M in the last 12 months, with 20% of the sale value made under pre-set 10b5-1 plans. The largest seller was Alaleh Nouri (Vice president), with $409K. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling PROCEPT BioRobotics
From the latest filingsOverall: more buying than selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns PRCT
255 funds and institutions reported PRCT shares worth $1.3B at the end of Q2 2026, about 100% of the company. The largest holder is BlackRock, Inc. with 8.6%.
Funds and institutions (13F) 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 4.87M | 8.56% | $110M | +12% |
| T. Rowe Price Investment Management, Inc. | 3.27M | 5.74% | $73.7M | -0% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2.82M | 4.96% | $63.8M | -9% |
| Vanguard Portfolio Management LLC | 2.53M | 4.44% | $57.1M | +4% |
| Vanguard Capital Management LLC | 2.46M | 4.32% | $55.6M | +3% |
| Chicago Capital, LLC | 2.07M | 3.64% | $46.8M | -4% |
| State Street Corp | 1.62M | 2.84% | $36.5M | +6% |
| California State Teachers Retirement System | 1.55M | 2.72% | $68.5M | +2104% |
| Geode Capital Management, LLC | 1.48M | 2.61% | $33.5M | +9% |
| FMR LLC (Fidelity) | 1.44M | 2.54% | $32.6M | -1% |
| T. Rowe Price Associates | 1.33M | 2.34% | $30.1M | +120% |
| Wellington Management Group LLP | 1.27M | 2.24% | $28.8M | +48% |
| Federated Hermes, Inc. | 1.25M | 2.20% | $28.3M | +619% |
| Jupiter Topco LLC | 1.10M | 1.94% | $24.9M | – |
| Frontier Capital Management Co LLC | 1.09M | 1.92% | $24.6M | +79% |
| Soleus Capital Management, L.P. | 1.00M | 1.76% | $22.6M | +527% |
| Champlain Investment Partners, LLC | 981,381 | 1.72% | $22.2M | -14% |
| Baillie Gifford & Co | 911,751 | 1.60% | $20.6M | -6% |
| Fiera Capital Corp | 774,569 | 1.36% | $17.5M | -20% |
| LMR Partners LLP | 721,608 | 1.27% | $16.3M | – |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, PRCT insiders reported $11M of open-market purchases and $709K of sales. 20% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | Pooja Sharma | Chief Strat/Marketing Of | Sale | 4,710 | $19.71 | $92.9K | Form 4 |
| Sep 9, 2026 | Alaleh Nouri | Vice president | Sale | 297 | $20.95 | $6.2K | Form 4 |
| Sep 9, 2026 | Barry L Templin | Vice president | Sale | 373 | $20.95 | $7.8K | Form 4 |
| Aug 7, 2026 | Larry L Wood | CEO | Purchase | 23,900 | $20.85 | $498K | Form 4 |
| Jun 8, 2026 | Alaleh Nouri | Vice president | Sale | 285 | $28.48 | $8.1K | Form 4 |
| Jun 8, 2026 | Kevin Waters | CFO | Sale | 357 | $28.48 | $10.2K | Form 4 |
| Jun 8, 2026 | Barry L Templin | Vice president | Sale | 358 | $28.48 | $10.2K | Form 4 |
| Mar 19, 2026 | Alaleh Nouri | Vice president | Sale plan | 3,031 | $25.82 | $78.3K | Form 4 |
| Mar 19, 2026 | Alaleh Nouri | Vice president | Sale plan | 2,332 | $26.15 | $61K | Form 4 |
| Mar 17, 2026 | Alaleh Nouri | Vice president | Sale | 304 | $28.15 | $8.6K | Form 4 |
| Mar 17, 2026 | Kevin Waters | CFO | Sale | 706 | $28.15 | $19.9K | Form 4 |
| Mar 10, 2026 | Alaleh Nouri | Vice president | Sale | 145 | $26.74 | $3.9K | Form 4 |
| Mar 10, 2026 | Alaleh Nouri | Vice president | Sale | 3,098 | $25.60 | $79.3K | Form 4 |
| Mar 9, 2026 | Antal Rohit Desai | Director | Purchase | 43,581 | $24.08 | $1M | Form 4 |
| Mar 9, 2026 | Antal Rohit Desai | Director | Purchase | 1,300 | $25.42 | $33K | Form 4 |
| Mar 9, 2026 | Antal Rohit Desai | Director | Purchase | 53,818 | $24.91 | $1.3M | Form 4 |
| Mar 6, 2026 | Antal Rohit Desai | Director | Purchase | 53,763 | $24.10 | $1.3M | Form 4 |
| Mar 6, 2026 | Antal Rohit Desai | Director | Purchase | 106,554 | $23.33 | $2.5M | Form 4 |
| Mar 6, 2026 | Alaleh Nouri | Vice president | Sale | 6,892 | $23.70 | $163K | Form 4 |
| Mar 6, 2026 | Kevin Waters | CFO | Sale | 6,721 | $23.70 | $159K | Form 4 |
| Mar 5, 2026 | Antal Rohit Desai | Director | Purchase | 142,498 | $25.44 | $3.6M | Form 4 |
| Mar 5, 2026 | Antal Rohit Desai | Director | Purchase | 24,748 | $26.41 | $654K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Antal Rohit Desai | Director | $10.5M | – | Mar 9, 2026 |
| Larry L Wood | President, CEO, Director | $498K | – | Aug 7, 2026 |
| Alaleh Nouri | EVP, CLO, CORP. SEC. | – | $409K | Sep 9, 2026 |
| Kevin Waters | EVP, CFO | – | $189K | Jun 8, 2026 |
| Pooja Sharma | Chief Strat/Marketing Officer | – | $92.9K | Nov 6, 2026 |
| Barry L Templin | EVP, Chief Technology Officer | – | $18K | Sep 9, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
PRCT short interest
High short interest. 13.7% of PRCT shares are sold short: about 1 share in 7. Over the last 12 reports the number of shares short went up 17%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 7.86M PRCT shares were sold short, 13.7% of the shares outstanding, up 4.8% from the report before. At the average daily volume of 871,513 shares, buying them all back would take about 9.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 7.86M | 13.66% | +5% | 871,513 | 9.0 |
| Oct 15, 2026 | 7.50M | 13.10% | +1% | 1.35M | 5.6 |
| Sep 30, 2026 | 7.43M | 12.97% | -0% | 1.40M | 5.3 |
| Sep 15, 2026 | 7.44M | 12.99% | +3% | 1.34M | 5.6 |
| Aug 31, 2026 | 7.25M | 12.66% | -6% | 846,305 | 8.6 |
| Aug 14, 2026 | 7.71M | 13.45% | +9% | 2.22M | 3.5 |
| Jul 31, 2026 | 7.09M | 12.38% | -9% | 1.38M | 5.1 |
| Jul 15, 2026 | 7.75M | 13.62% | +1% | 1.59M | 4.9 |
| Jun 30, 2026 | 7.65M | 13.45% | +1% | 1.97M | 3.9 |
| Jun 15, 2026 | 7.61M | 13.37% | +12% | 1.40M | 5.4 |
| May 29, 2026 | 6.78M | 11.92% | +1% | 1.26M | 5.4 |
| May 15, 2026 | 6.72M | 11.81% | +12% | 1.67M | 4.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
PROCEPT BioRobotics company events
PROCEPT BioRobotics filed 9 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 4, 2026.
- Nov 4, 2026ResultsReleased financial results. Filing
- Oct 2, 2026LeadershipThe board of directors of PROCEPT BioRobotics Corporation approved (i) an increase in the size of the Board from nine members to ten members, (ii) appointed Dr. Michael Mack as a new member of the Board to fill the resulting vacancy, effective immediately. Filing
- Sep 24, 2026AgreementPROCEPT BioRobotics Corporation entered into a Third Amendment to Loan and Security Agreement with Canadian Imperial Bank of Commerce, which amends the Loan and Security Agreement, dated as of October 6, 2022, by and between the Company and CIBC, as previously amended by the First Amendment to Loan… Filing
- Aug 4, 2026ResultsReleased financial results. Filing
- Jun 10, 2026VoteReported shareholder vote results. Filing
- Apr 29, 2026ResultsReleased financial results. Filing
- Mar 6, 2026LeadershipThe board of directors of PROCEPT BioRobotics Corporation approved (i) an increase in the size of the Board from eight members to nine members, (ii) appointed Mr. Daniel Puckett as a new member of the Board to fill the resulting vacancy, and (iii) appointed Mr. Puckett as a member of the Audit… Filing
- Feb 26, 2026AnnouncementShared information with investors. Filing
- Feb 25, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
PROCEPT BioRobotics financials
Famous investors that hold PRCT
2 of the 50 well-known investors we track reported holding PRCT in their latest 13F filing. The largest position is Israel Englander's, worth $22.2M.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 1.22M | $22.2M | 0.0% | +95% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 278,073 | $5.1M | 0.0% | +2105% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named PRCT in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Oct 30, 2026 | Vanguard Capital Management | 13G/A | 5.0% |
| Oct 30, 2026 | Vanguard Capital Management | 13G/A | 5.0% |
Questions about PROCEPT BioRobotics Corp (PRCT) stock
Who owns the most PRCT stock?
The largest reported owner of PROCEPT BioRobotics Corp (PRCT) is BlackRock, Inc., with 8.6% of the company. In total, 255 funds and institutions reported holding PRCT at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are PRCT insiders buying or selling?
In the last 12 months, PRCT insiders reported 8 open-market purchases worth $11M and 14 sales worth $709K. The latest trade was on Nov 6, 2026. See every trade.
What is the short interest in PRCT?
As of Oct 30, 2026, 7.86M PRCT shares were sold short, 13.7% of the shares outstanding, up 4.8% from the report before. At the average daily volume of 871,513 shares, buying them all back would take about 9.0 trading days (days to cover). See the history.
Which famous investors hold PRCT?
2 of the 50 well-known investors we track reported PRCT in their latest 13F filing, including Israel Englander, Ken Griffin. The largest position is worth $22.2M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.